Weight-loss drug manufacturer Novo Nordisk cuts 9000 jobs — and its profit forecastBy Mario Cazombo / September 10, 2025 New CEO Mike Doustdar is kitchen-sinking the costs of restructuring the company to focus on diabetes and anti-obesity drugs.
Book Review: The Financial Restructuring Tool Set August 6, 2025 / Book Reviews, Corporate Finance, Drivers of Value, Economics, Financial Statement Analysis, General
